Toward precision medicine in glioblastoma: the promise and the challenges-Reference-Cited by-同舟云学术

Toward precision medicine in glioblastoma: the promise and the challenges

Published:2015-05-01 Issue:8 Volume:17 Page:1051-1063
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:Neuro Oncol

Author:

Prados Michael D.,Byron Sara A.,Tran Nhan L.,Phillips Joanna J.,Molinaro Annette M.,Ligon Keith L.,Wen Patrick Y.,Kuhn John G.,Mellinghoff Ingo K.,de Groot John F.,Colman Howard,Cloughesy Timothy F.,Chang Susan M.,Ryken Timothy C.,Tembe Waibhav D.,Kiefer Jeffrey A.,Berens Michael E.,Craig David W.,Carpten John D.,Trent Jeffrey M.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/17/8/1051/6839073/nov031.pdf

Reference144 articles.

1. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

2. A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme

3. Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006

4. Stereotactic Histologic Correlations of Computed Tomography- and Magnetic Resonance Imaging-Defined Abnormalities in Patients With Glial Neoplasms

5. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Doxorubicin-loaded liposome-like particles embedded in chitosan/hyaluronic acid-based hydrogels as a controlled drug release model for local treatment of glioblastoma;International Journal of Biological Macromolecules;2024-10

2. High expression of SIGLEC7 may promote M2-type macrophage polarization leading to adverse prognosis in glioma patients;Frontiers in Immunology;2024-08-15

3. Evaluation of ex vivo drug combination optimization platform in recurrent high grade astrocytic glioma: An interventional, non-randomized, open-label trial protocol;PLOS ONE;2024-07-26

4. Multiplatform molecular profiling and functional genomic screens identify prognostic signatures and mechanisms underlying MEK inhibitor response in somaticNF1mutant glioblastoma;2024-07-03

5. Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data;Journal of Neuro-Oncology;2024-05-29